Shepherd MD*, Richards KM, Winegar AL. Prescription drug payment times by Medicare Part D plans: results of a national study. J Am Pharm Assoc. 2007 Nov/Dec; 47(6):695-701.

Abstract. Objective: To determine the average payment time from Medicare Part D plans to
community pharmacies for prescription drugs dispensed to Medicare beneficiaries.
Design: Nonexperimental time series.
Setting: United States in January to December 2006.
Participants: 145 independent pharmacies and 17 regional chain pharmacy firms.
Intervention: Review of 2,944,526 Medicare Part D prescription drug claims
adjudicated in 2006.
Main outcome measures: Median payment time and the number and proportion
of claims paid, controlling for month of claim adjudication, pharmacy type, and Part
D plan.
Results: The median payment time for 2006 claims filed by all pharmacies in this
study was 29.0 days (mean 39.1). The median payment time was greater for independent
pharmacies (median 31.0, mean 49.1) than chain pharmacies (median 29.0, mean
36.5). Payment was slower during the first few months of the Medicare Part D benefit
than later in the year. By December, approximately 40% of the claims were not paid
within 30 days. Within the 12 plans identified as having the greatest number of claims
in the sample, the median payment time ranged from 23.0 days to 36.0 days.
Conclusion: Payment times improved during 2006, but a sizable proportion of
claims were not paid within 30 days. Chain pharmacies received payments sooner than
independent pharmacies. Additionally, a wide variation in median payment times was
observed for Part D plans. The results of this study, based on actual claims data, are
not in agreement with findings from a survey of Part D plans reported by the Centers
for Medicare & Medicaid Services.
Keywords: Medicare Part D, prescription drug plans, payment systems.

[...]

Americas Watchdog Warns About Drug & Tobacco Counterfeiters in China & India and the Dire Need to Stop Them before it’s Too Late

After a 12 month long investigation into counterfeit pharmaceuticals and tobacco products Americas Watchdog launched Global Piracy & Counterfeiting Consultants as a way to address the issue of global counterfeiting and piracy( Http://GP-CC.Com ). Within the last few months public attention has been focused on China and India for making toys with lead based paint,…

[...]

Report: China drug ingredients unregulated

At least 82 Chinese companies at the world's largest pharmaceutical ingredient trade show in Italy are not government-certified, The New York Times reports. The companies included Honor International Pharmtech, which allegedly sent counterfeit drugs to the United States, and Orient Pacific International, whose owner has been charged with selling counterfeit drugs for serious diseases like…

[...]

Government & Multilateral Initiatives

Government & Multilateral Initiatives The fight against counterfeit medicines is a global one, involving many governmental and inter-governmental organizations. This page provides a guide to those organizations. If you would like to add an initiative to this page, please contact us. World Health Organization Counterfeit medicines. Fact Sheet No. 275. Updated February 2006. General Information…

[...]

Protecting Yourself and Your Family

Patients and providers need to be on alert and aware of the real risks associated with online pharmacies and counterfeit medicines. Learn about counterfeit medicines in order to avoid, detect, and report them. You can minimize your risk of getting a counterfeit medicine, and you can also fight back by reporting these cases to the…

[...]

Counterfeit Drugs In the News

  New Report Warns 14 Types of Counterfeit Artesunate are Circulating in SE Asia The Wellcome Trust recently updated its report on counterfeit Artesunate, an anti-malarial medicine made by Guilin Pharma. Although Artesunate bears a hologram for security, multiple counterfeit forms of this hologram have been discovered and identified. According to the report’s author: “Although,…

[...]

Nigeria: Dangers of Drug Counterfeiting

"The problem of counterfeit drugs and other regulated products is rapidly rearing its ugly head in developed countries and this is fueled by purchase of drugs via the internet. The negative impact of counterfeit drugs and other regulated products knows no boundaries. Resistant strains of micro-organisms do not need visa to travel from country to…

[...]

Partnership for Safe Medicines Commends New Anti-Counterfeiting Agreement

WASHINGTON, D.C. (Oct. 24, 2007) — The Partnership for Safe Medicines commends yesterday's announcement by the U.S. Trade Representative of a new six-country Anti-Counterfeiting Trade Agreement (ACTA). The purpose of ACTA is to step up enforcement efforts against international counterfeiters.

[...]

Counterfeit Drugs, Killing

Many compelling reasons present themselves to oppose the spread of counterfeit drugs. Fakes represent theft of millions upon millions of dollars of value, undermine international protection of intellectual property, and its damage often redounds — unjustly — to pharmaceutical companies. And counterfeits kill. This article in The American, the magazine of the American Enterprise Institute,…

[...]